NCT06045221 A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin Status COMPLETED Phase PHASE3
NCT06041217 A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range Status COMPLETED Phase PHASE3
NCT06027567 The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure Status COMPLETED Phase PHASE4
NCT06005012 Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM Status UNKNOWN Phase PHASE2
NCT05996874 A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants Status COMPLETED Phase PHASE1
NCT05996848 A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight Status COMPLETED Phase PHASE3
NCT05950516 Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Status UNKNOWN Phase PHASE3
NCT05920889 Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies Status COMPLETED Phase PHASE2
NCT05891496 A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT05890976 Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3) Status COMPLETED Phase PHASE3
NCT05877547 A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) Status COMPLETED Phase PHASE2
NCT05829460 Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Status WITHDRAWN Phase PHASE2
NCT05822830 A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities Status COMPLETED Phase PHASE3
NCT05822609 Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes Status RECRUITING Phase PHASE2
NCT05813925 A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight Status COMPLETED Phase PHASE3
NCT05813912 A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3